ANUH PHARMA
Quarterly Results Analysis [Dec2024]
ANUH PHARMA Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹160 Cr | ₹166 Cr | ₹138 Cr | ₹164 Cr | ₹172 Cr | ₹150 Cr | ₹161 Cr | ₹157 Cr |
Expenses | ₹145 Cr | ₹149 Cr | ₹127 Cr | ₹145 Cr | ₹148 Cr | ₹132 Cr | ₹148 Cr | ₹143 Cr |
Operating Income | ₹15 Cr | ₹17 Cr | ₹11 Cr | ₹19 Cr | ₹24 Cr | ₹18 Cr | ₹14 Cr | ₹14 Cr |
Other Income | ₹1 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹13 Cr | ₹18 Cr | ₹12 Cr | ₹20 Cr | ₹25 Cr | ₹18 Cr | ₹15 Cr | ₹13 Cr |
Profit After Tax | ₹10 Cr | ₹15 Cr | ₹10 Cr | ₹15 Cr | ₹19 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr |
EPS | ₹2.06 | ₹3.00 | ₹1.90 | ₹3.06 | ₹3.81 | ₹2.76 | ₹2.35 | ₹1.92 |
Industry Peers & Returns | 1W | 1M | 1Y |
ANUH PHARMA | 18.5% | 15.2% | -29.9% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
ANUH PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.88 % |
Y-o-Y | -7.31 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹160 Cr | -3.88 | |
Sep2024 | ₹166 Cr | 20.34 | |
Jun2024 | ₹138 Cr | -15.85 | |
Mar2024 | ₹164 Cr | -4.77 | |
Dec2023 | ₹172 Cr | 15.09 | |
Sep2023 | ₹150 Cr | -7.40 | |
Jun2023 | ₹161 Cr | 2.65 | |
Mar2023 | ₹157 Cr | - |
ANUH PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -12.39 % |
Y-o-Y | -38.36 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹15 Cr | -12.39 | |
Sep2024 | ₹17 Cr | 59.73 | |
Jun2024 | ₹11 Cr | -45.03 | |
Mar2024 | ₹19 Cr | -19.87 | |
Dec2023 | ₹24 Cr | 33.59 | |
Sep2023 | ₹18 Cr | 28.52 | |
Jun2023 | ₹14 Cr | -1.81 | |
Mar2023 | ₹14 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -8.85 % |
Y-o-Y | -33.50 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 9.27% | -8.85 | |
Sep2024 | 10.17% | 32.77 | |
Jun2024 | 7.66% | -34.70 | |
Mar2024 | 11.73% | -15.85 | |
Dec2023 | 13.94% | 16.07 | |
Sep2023 | 12.01% | 38.84 | |
Jun2023 | 8.65% | -4.42 | |
Mar2023 | 9.05% | - |
ANUH PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -31.24 % |
Y-o-Y | -45.88 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹10 Cr | -31.24 | |
Sep2024 | ₹15 Cr | 58.21 | |
Jun2024 | ₹10 Cr | -38.09 | |
Mar2024 | ₹15 Cr | -19.64 | |
Dec2023 | ₹19 Cr | 38.14 | |
Sep2023 | ₹14 Cr | 17.72 | |
Jun2023 | ₹12 Cr | 22.12 | |
Mar2023 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -28.48 % |
Y-o-Y | -41.67 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 6.48 % | -28.48 | |
Sep2024 | 9.06 % | 31.49 | |
Jun2024 | 6.89 % | -26.47 | |
Mar2024 | 9.37 % | -15.66 | |
Dec2023 | 11.11 % | 20.11 | |
Sep2023 | 9.25 % | 27.06 | |
Jun2023 | 7.28 % | 18.95 | |
Mar2023 | 6.12 % | - |
ANUH PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -31.33 % |
Y-o-Y | -45.93 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.06 | -31.33 | |
Sep2024 | ₹3 | 57.89 | |
Jun2024 | ₹1.9 | -37.91 | |
Mar2024 | ₹3.06 | -19.69 | |
Dec2023 | ₹3.81 | 38.04 | |
Sep2023 | ₹2.76 | 17.45 | |
Jun2023 | ₹2.35 | 22.40 | |
Mar2023 | ₹1.92 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD